Printer Friendly

A. L. LABORATORIES ISSUES CORRECTION TO IBES EARNINGS ESTIMATE FOR THE THIRD QUARTER 1993

 FORT LEE, N.J., Nov. 9 /PRNewswire/ -- A. L. Laboratories, Inc. (NYSE: BMD) said today that the news item that was reported yesterday on the Dow Jones News Service quoted an erroneous earnings estimate for the Company that was provided by IBES.
 Dow Jones News Service reported an IBES estimate of $0.09 per share for the third quarter ended September 30, 1993; analysts following the Company from PaineWebber, Kidder Peabody and County NatWest had published earnings estimates for the quarter in the range of $0.03 to $0.05 per share. A. L. Laboratories reported earnings of $0.03 per share for the three month period.
 A. L. Laboratories is a multinational manufacturer and marketer of specialized and value-added branded pharmaceuticals and animal health micronutrients, with plant sites in Illinois, Maryland, New Jersey, New York, North Carolina, Washington State, Denmark and Indonesia.
 -0- 11/9/93
 /CONTACT: Iris Daniels, investor relations manager of A.L. Laboratories, 201-947-7774, or Donna N. Stein, APR, or Lisa Carlton of Morgen-Walke Associates, 212-850-5600/
 (BMD)


CO: A.L. Laboratories, Inc. ST: New Jersey IN: MTC SU: ERN

SH -- NY044 -- 2176 11/09/93 10:27 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 9, 1993
Words:192
Previous Article:ELECTROCOM AUTOMATION SAYS DELAYS IN CONTRACT AWARDS WILL IMPACT 1994 RESULTS
Next Article:NYMAGIC, INC. REPORTS THIRD-QUARTER EARNINGS, SEPT. 30, 1993
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters